Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
批准号:
10394866
负责人:
STUART B GOODMAN
金额:
$42.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-05 至 2024-04-30
关键词:
3D PrintAffectAge-YearsAnti-Inflammatory AgentsAreaArthritisBiocompatible MaterialsBiologicalBiomimeticsBlood VesselsBone MarrowBone RegenerationBone necrosisBone remodelingCartilageCell DeathCell TherapyCuesDegenerative polyarthritisDiagnosisDiseaseDisease ProgressionDistalEarly InterventionEarly treatmentEngineeringEtiologyFemurGenetic EngineeringGoalsHeadHip JointHip region structureImplantIncidenceIndividualInterleukin-4JointsLeadMaintenanceMechanicsMedicalMesenchymal Stem CellsNatureNecrosisOperative Surgical ProceduresOrthopedic SurgeryOryctolagus cuniculusOsseointegrationOsteogenesisPainPatientsPorosityProgressive DiseasePropertyRaceSignal TransductionSteroidsTestingTherapeutic EffectTimeTissue EngineeringTotal Hip ReplacementUnited StatesUp-RegulationWeight-Bearing statearticular cartilagebonebone healingcaprolactonecytokinedensitydesignimplantationimprovedmechanical loadmechanical propertiesnovelnovel strategiesosteogenicpreconditioningpreservationpreventreconstitutionregenerativerepairedscaffoldstem cell therapysuccesstricalcium phosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Osteonecrosis of the femoral head (ONFH) is a potentially debilitating disease that is increasing in incidence
worldwide. In the United States alone, approximately 20,000 cases of ONFH are diagnosed each year. Up to
18% of total hip replacements (THR) performed in the USA are a result of ONFH. In the early stages of ONFH,
various hip joint preserving medical and surgical treatments have been tried with limited success. This is due to
the fact that maintenance of the patient's own femoral head requires both mechanical and biological strategies
to withstand intermittent loading and, at the same time, reconstitute the necrotic femoral head segment. Our
long-term goal is to improve the treatment of ONFH using a tissue engineering approach. Our overall
hypothesis is that the combination of a biomimetic functionally-graded scaffold (FGS), and preconditioned or
genetically modified (GM) mesenchymal stem cells (MSCs) with anti-inflammatory, osteogenic and vascular
promoting signals will provide enhanced mechanical and biological cues to reconstitute the osteonecrotic
segment in ONFH. To test these hypotheses, our established team with expertise in orthopaedic surgery,
biomaterials, and tissue engineering proposes the following Specific Aims: Aim 1 is to establish the efficacy of
FGS for reconstitution of the femoral head in steroid-induced ONFH. Aim 2 is to establish superior efficacy of
enhanced, preconditioned or GM MSCs, compared to unmodified MSCs for reconstitution of bone in the
femoral head in steroid-induced ONFH. Aim 3 is to confirm that the combination of the FGS and enhanced
MSCs optimizes the mechanical and biological properties in ONFH to a greater degree than either treatment or
core decompression alone. This directly translational project will revolutionize and significantly improve the
treatment of ONFH by introducing two novel adjunctive therapies consisting of a biomimetic resorbable load-
bearing implant together with preconditioned or GM MSCs for femoral head reconstitution and preservation.
1"
"
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
CORR Insights®: CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor- γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
CORR Insights®:CORR® ORS Richard A. 品牌奖:过氧化物酶体增殖物激活受体-γ (PPARG) 的破坏通过遗传变异和药理学调节增加骨坏死风险。
DOI:
10.1097/corr.0000000000000789
发表时间:
2019
期刊:
Clinical orthopaedics and related research
影响因子:
4.2
作者:
[Goodman,StuartB]
通讯作者:
Goodman,StuartB
DOI:
10.1002/jbm.a.36504
发表时间:
2018-10
期刊:
Journal of biomedical materials research. Part A
影响因子:
--
作者:
[Lin T, Kohno Y, Huang JF, Romero-Lopez M, Pajarinen J, Maruyama M, Nathan K, Yao Z, Goodman SB]
通讯作者:
Goodman SB
DOI:
10.1186/s13287-023-03260-4
发表时间:
2023-04-21
期刊:
Stem cell research & therapy
影响因子:
7.5
作者:
[]
通讯作者:
DOI:
10.1088/1758-5090/abc8de
发表时间:
2021-03-10
期刊:
Biofabrication
影响因子:
9
作者:
[Potyondy T, Uquillas JA, Tebon PJ, Byambaa B, Hasan A, Tavafoghi M, Mary H, Aninwene GE 2nd, Pountos I, Khademhosseini A, Ashammakhi N]
通讯作者:
Ashammakhi N
DOI:
10.1016/j.actbio.2020.03.017
发表时间:
2020-05
期刊:
Acta biomaterialia
影响因子:
9.7
作者:
[Jämsen E, Pajarinen J, Kouri VP, Rahikkala A, Goodman SB, Manninen M, Nordström DC, Eklund KK, Nurmi K]
通讯作者:
Nurmi K
共 11 条
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
-
批准号:10658324
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2023
-
负责人:STUART B GOODMAN
-
依托单位:
Customized MSCs to Enhance Healing of Bone Defects
-
批准号:10115615
-
项目类别:
-
资助金额:$34.69万
-
财政年份:2018
-
负责人:STUART B GOODMAN
-
依托单位:
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
-
批准号:9921203
-
项目类别:
-
资助金额:$42.77万
-
财政年份:2018
-
负责人:STUART B GOODMAN
-
依托单位:
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
-
批准号:9594129
-
项目类别:
-
资助金额:$45.34万
-
财政年份:2018
-
负责人:STUART B GOODMAN
-
依托单位:
Customized MSCs to Enhance Healing of Bone Defects
-
批准号:9897409
-
项目类别:
-
资助金额:$34.73万
-
财政年份:2018
-
负责人:STUART B GOODMAN
-
依托单位:
Enhanced Bone Healing Around Implants by Transplanted NF-kB Driven Immunomodulating MSCs
-
批准号:9528468
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Enhanced Bone Healing Around Implants by Transplanted NF-kB Driven Immunomodulating MSCs
-
批准号:10222569
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Wear Particle Disease and NF-kappa B Signaling
-
批准号:8419372
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Wear Particle Disease and NF-kappa B Signaling
-
批准号:8543631
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Wear Particle Disease and NF-kappa B Signaling
-
批准号:8733519
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Enhanced Bone Healing Around Implants by Transplanted NF-kB Driven Immunomodulating MSCs
-
批准号:9762583
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Enhanced Bone Healing Around Implants by Transplanted NF-kB Driven Immunomodulating MSCs
-
批准号:9979754
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Wear Particle Disease and NF-kappa B Signaling
-
批准号:9110125
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Enhanced Bone Healing Around Implants by Transplanted NF-kB Driven Immunomodulating MSCs
-
批准号:9379438
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2012
-
负责人:STUART B GOODMAN
-
依托单位:
Biological Strategies to Mitigate the Adverse Effects of Polymeric Wear Particles
-
批准号:8762272
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
Biological Strategies to Mitigate the Adverse Effects of Polymeric Wear Particles
-
批准号:8514518
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
Biological Strategies to Mitigate the Adverse Effects of Polymeric Wear Particles
-
批准号:8264062
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
Chemokine Directed Cell Trafficking during Continuous Infusion of Wear Particles
-
批准号:7664524
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
Chemokine Directed Cell Trafficking during Continuous Infusion of Wear Particles
-
批准号:7497087
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
Chemokine Directed Cell Trafficking during Continuous Infusion of Wear Particles
-
批准号:7893127
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2007
-
负责人:STUART B GOODMAN
-
依托单位:
海外基金